Armodafinil Pregnancy and Breastfeeding Warnings
Armodafinil is also known as: Nuvigil
Armodafinil Pregnancy Warnings
Armodafinil has been assigned to pregnancy category C by the FDA. Animal studies (i.e., rats) have revealed evidence of developmental toxicity at clinically relevant doses. There are no controlled data in human pregnancy; however, armodafinil and modafinil have been associated with two cases of intrauterine growth retardation and one case of spontaneous abortion. Armodafinil is only recommended for use during pregnancy when benefit outweighs risk.
Oral administration (60, 200, or 600 mg/kg/day) to pregnant rats throughout organogenesis resulted in increased incidences of fetal visceral and skeletal variations and decreased fetal body weights. The effect of armodafinil on labor and delivery in humans is unknown.
Armodafinil Breastfeeding Warnings
There are no data on the excretion of armodafinil into human milk. The manufacturer recommends that caution be used when administering armodafinil to nursing women.
- armodafinil Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.